• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

免疫和非免疫细胞基质作为肝癌微环境的意义——从炎症到肝癌进展。

Significance of Immune and Non-Immune Cell Stroma as a Microenvironment of Hepatocellular Carcinoma-From Inflammation to Hepatocellular Carcinoma Progression.

机构信息

Department of Correct, Clinical and Imaging Anatomy, Chair of Fundamental Sciences, Medical University of Lublin, Jaczewskiego 4, 20-090 Lublin, Poland.

Chair and Department of Forensic Medicine, Medical University of Lublin, Jaczewskiego 8b, 20-090 Lublin, Poland.

出版信息

Int J Mol Sci. 2024 Sep 24;25(19):10233. doi: 10.3390/ijms251910233.

DOI:10.3390/ijms251910233
PMID:39408564
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11475949/
Abstract

Hepatocellular carcinoma (HCC) is the most common liver cancer as well as the most prevalent cause of death in the adult patient population with cirrhosis. The occurrence of HCC is primarily caused by chronic liver inflammation that might occur because of a viral infection, non-alcoholic fatty liver disease (NAFLD), or various lifestyle-associated factors. The objective of this review was to summarize the current knowledge regarding the microenvironment of HCC, indicating how immune- and non-immune-cell stroma might affect the onset and progression of HCC. Therefore, in the following narrative review, we described the role of tumor-infiltrating neutrophils, bone-marrow-derived cells, tumor-associated mast cells, cancer-associated fibroblasts, tumor-associated macrophages, liver-sinusoidal endothelial cells, lymphocytes, and certain cytokines in liver inflammation and the further progression to HCC. A better understanding of the HCC microenvironment might be crucial to introducing novel treatment strategies or combined therapies that could lead to more effective clinical outcomes.

摘要

肝细胞癌 (HCC) 是最常见的肝癌,也是肝硬化成年患者群体中最常见的死亡原因。HCC 的发生主要是由慢性肝脏炎症引起的,这种炎症可能是由于病毒感染、非酒精性脂肪性肝病 (NAFLD) 或各种与生活方式相关的因素引起的。本综述的目的是总结 HCC 微环境的现有知识,指出免疫和非免疫细胞基质如何影响 HCC 的发生和进展。因此,在下面的叙述性综述中,我们描述了肿瘤浸润中性粒细胞、骨髓来源细胞、肿瘤相关肥大细胞、癌相关成纤维细胞、肿瘤相关巨噬细胞、肝窦内皮细胞、淋巴细胞和某些细胞因子在肝脏炎症和进一步发展为 HCC 中的作用。更好地了解 HCC 微环境对于引入新的治疗策略或联合治疗可能导致更有效的临床结果可能至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/955f/11475949/7883b49123e7/ijms-25-10233-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/955f/11475949/6ca3c28b2b68/ijms-25-10233-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/955f/11475949/7883b49123e7/ijms-25-10233-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/955f/11475949/6ca3c28b2b68/ijms-25-10233-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/955f/11475949/7883b49123e7/ijms-25-10233-g002.jpg

相似文献

1
Significance of Immune and Non-Immune Cell Stroma as a Microenvironment of Hepatocellular Carcinoma-From Inflammation to Hepatocellular Carcinoma Progression.免疫和非免疫细胞基质作为肝癌微环境的意义——从炎症到肝癌进展。
Int J Mol Sci. 2024 Sep 24;25(19):10233. doi: 10.3390/ijms251910233.
2
Immune control in hepatocellular carcinoma development and progression: role of stromal cells.肝细胞癌发生和进展中的免疫控制:基质细胞的作用
Semin Liver Dis. 2014 Nov;34(4):376-88. doi: 10.1055/s-0034-1394138. Epub 2014 Nov 4.
3
Metabolic reprogramming of immune cells: Shaping the tumor microenvironment in hepatocellular carcinoma.免疫细胞的代谢重编程:塑造肝细胞癌的肿瘤微环境。
Cancer Med. 2021 Sep;10(18):6374-6383. doi: 10.1002/cam4.4177. Epub 2021 Aug 13.
4
Current perspectives on the immunosuppressive tumor microenvironment in hepatocellular carcinoma: challenges and opportunities.当前对肝癌免疫抑制性肿瘤微环境的认识:挑战与机遇。
Mol Cancer. 2019 Aug 29;18(1):130. doi: 10.1186/s12943-019-1047-6.
5
Tumor-Associated Neutrophils Recruit Macrophages and T-Regulatory Cells to Promote Progression of Hepatocellular Carcinoma and Resistance to Sorafenib.肿瘤相关中性粒细胞招募巨噬细胞和 T 调节细胞促进肝细胞癌进展和索拉非尼耐药。
Gastroenterology. 2016 Jun;150(7):1646-1658.e17. doi: 10.1053/j.gastro.2016.02.040. Epub 2016 Feb 26.
6
Analysis of Liver Microenvironment during Early Progression of Non-Alcoholic Fatty Liver Disease-Associated Hepatocellular Carcinoma in Zebrafish.分析斑马鱼非酒精性脂肪性肝病相关肝细胞癌早期进展过程中的肝微环境。
J Vis Exp. 2021 Apr 1(170). doi: 10.3791/62457.
7
Emerging Role of Cancer-Associated Fibroblasts in Progression and Treatment of Hepatocellular Carcinoma.癌症相关成纤维细胞在肝细胞癌进展和治疗中的新作用。
Int J Mol Sci. 2023 Feb 15;24(4):3941. doi: 10.3390/ijms24043941.
8
Deviations of the immune cell landscape between healthy liver and hepatocellular carcinoma.健康肝脏与肝癌之间免疫细胞景观的差异。
Sci Rep. 2018 Apr 18;8(1):6220. doi: 10.1038/s41598-018-24437-5.
9
Neutrophils: Driving inflammation during the development of hepatocellular carcinoma.中性粒细胞:在肝细胞癌发展过程中引发炎症。
Cancer Lett. 2021 Dec 1;522:22-31. doi: 10.1016/j.canlet.2021.09.011. Epub 2021 Sep 10.
10
Glycolytic activation of peritumoral monocytes fosters immune privilege via the PFKFB3-PD-L1 axis in human hepatocellular carcinoma.肿瘤周围单核细胞的糖酵解激活通过 PFKFB3-PD-L1 轴促进人肝癌中的免疫特权。
J Hepatol. 2019 Aug;71(2):333-343. doi: 10.1016/j.jhep.2019.04.007. Epub 2019 May 7.

本文引用的文献

1
Effect of cytokines on advanced hepatocellular carcinoma prognosis receiving radiotherapy and tislelizumab plus anlotinib: a single-center phase II clinical trial.细胞因子对接受放疗和替雷利珠单抗联合安罗替尼治疗的晚期肝细胞癌预后的影响:一项单中心 II 期临床试验。
Sci Rep. 2024 May 20;14(1):11486. doi: 10.1038/s41598-024-62523-z.
2
Mast Cells in the Microenvironment of Hepatocellular Carcinoma Confer Favorable Prognosis: A Retrospective Study using QuPath Image Analysis Software.肝癌微环境中的肥大细胞赋予有利预后:使用 QuPath 图像分析软件的回顾性研究。
J Vis Exp. 2024 Apr 12(206). doi: 10.3791/66743.
3
Acetyl-CoA metabolic accumulation promotes hepatocellular carcinoma metastasis via enhancing CXCL1-dependent infiltration of tumor-associated neutrophils.
乙酰辅酶 A 代谢积累通过增强 CXCL1 依赖性肿瘤相关中性粒细胞浸润促进肝细胞癌转移。
Cancer Lett. 2024 Jun 28;592:216903. doi: 10.1016/j.canlet.2024.216903. Epub 2024 Apr 24.
4
The relationship between tumor-infiltrating neutrophils and clinical outcomes in patients with resectable hepatocellular carcinoma.可切除肝细胞癌患者中肿瘤浸润中性粒细胞与临床结局的关系
BMC Cancer. 2024 Mar 11;24(1):327. doi: 10.1186/s12885-024-12074-3.
5
Endothelial cells in tumor microenvironment: insights and perspectives.肿瘤微环境中的内皮细胞:深入了解和展望。
Front Immunol. 2024 Feb 15;15:1367875. doi: 10.3389/fimmu.2024.1367875. eCollection 2024.
6
Key oncogenic signaling pathways affecting tumor-infiltrating lymphocytes infiltration in hepatocellular carcinoma: basic principles and recent advances.影响肝癌肿瘤浸润淋巴细胞浸润的关键致癌信号通路:基本原则和最新进展。
Front Immunol. 2024 Feb 15;15:1354313. doi: 10.3389/fimmu.2024.1354313. eCollection 2024.
7
Low-dose radiotherapy combined with dual PD-L1 and VEGFA blockade elicits antitumor response in hepatocellular carcinoma mediated by activated intratumoral CD8 exhausted-like T cells.低剂量放疗联合双重 PD-L1 和 VEGFA 阻断通过激活肿瘤内耗尽样 CD8 T 细胞介导的肝细胞癌的抗肿瘤反应。
Nat Commun. 2023 Nov 24;14(1):7709. doi: 10.1038/s41467-023-43462-1.
8
M2 macrophage-secreted exosomes promote metastasis and increase vascular permeability in hepatocellular carcinoma.M2 巨噬细胞分泌的外泌体促进肝癌转移并增加血管通透性。
Cell Commun Signal. 2023 Oct 30;21(1):299. doi: 10.1186/s12964-022-00872-w.
9
Retinoic Acid Signaling in Fatty Liver Disease.脂肪肝疾病中的视黄酸信号传导
Liver Res. 2023 Sep;7(3):189-195. doi: 10.1016/j.livres.2023.07.002. Epub 2023 Jul 16.
10
Liver endothelial cells in NAFLD and transition to NASH and HCC.非酒精性脂肪性肝病中的肝内皮细胞及向 NASH 和 HCC 的转变。
Cell Mol Life Sci. 2023 Oct 5;80(11):314. doi: 10.1007/s00018-023-04966-7.